Cargando…

P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS

Detalles Bibliográficos
Autores principales: Quach, H., Gironella, M., Lee, C., Popat, R., Cannell, P., Kasinathan, R. S., Chopra, B., Rogers, R., Ferron-Brady, G., Shafi-Harji, S., Patel, N., Opalinska, J., Gupta, I., Augustson, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430153/
http://dx.doi.org/10.1097/01.HS9.0000846632.03623.af
_version_ 1784779674776240128
author Quach, H.
Gironella, M.
Lee, C.
Popat, R.
Cannell, P.
Kasinathan, R. S.
Chopra, B.
Rogers, R.
Ferron-Brady, G.
Shafi-Harji, S.
Patel, N.
Opalinska, J.
Gupta, I.
Augustson, B.
author_facet Quach, H.
Gironella, M.
Lee, C.
Popat, R.
Cannell, P.
Kasinathan, R. S.
Chopra, B.
Rogers, R.
Ferron-Brady, G.
Shafi-Harji, S.
Patel, N.
Opalinska, J.
Gupta, I.
Augustson, B.
author_sort Quach, H.
collection PubMed
description
format Online
Article
Text
id pubmed-9430153
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94301532022-08-31 P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS Quach, H. Gironella, M. Lee, C. Popat, R. Cannell, P. Kasinathan, R. S. Chopra, B. Rogers, R. Ferron-Brady, G. Shafi-Harji, S. Patel, N. Opalinska, J. Gupta, I. Augustson, B. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430153/ http://dx.doi.org/10.1097/01.HS9.0000846632.03623.af Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Quach, H.
Gironella, M.
Lee, C.
Popat, R.
Cannell, P.
Kasinathan, R. S.
Chopra, B.
Rogers, R.
Ferron-Brady, G.
Shafi-Harji, S.
Patel, N.
Opalinska, J.
Gupta, I.
Augustson, B.
P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS
title P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS
title_full P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS
title_fullStr P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS
title_full_unstemmed P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS
title_short P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS
title_sort p941: safety and clinical activity of belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma (rrmm): dreamm-6 arm-a interim analysis
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430153/
http://dx.doi.org/10.1097/01.HS9.0000846632.03623.af
work_keys_str_mv AT quachh p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT gironellam p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT leec p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT popatr p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT cannellp p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT kasinathanrs p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT choprab p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT rogersr p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT ferronbradyg p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT shafiharjis p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT pateln p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT opalinskaj p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT guptai p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis
AT augustsonb p941safetyandclinicalactivityofbelantamabmafodotinwithlenalidomideplusdexamethasoneinpatientswithrelapsedrefractorymultiplemyelomarrmmdreamm6armainterimanalysis